Physicochemical Properties
Molecular Formula | C23H33NO |
Molecular Weight | 339.51 |
Exact Mass | 339.256 |
CAS # | 15266-38-3 |
PubChem CID | 5317303 |
Appearance | White to off-white solid powder |
Density | 1.0±0.1 g/cm3 |
Boiling Point | 456.2±45.0 °C at 760 mmHg |
Melting Point | 34-38℃ |
Flash Point | 156.1±18.1 °C |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.526 |
LogP | 7.7 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 11 |
Heavy Atom Count | 25 |
Complexity | 451 |
Defined Atom Stereocenter Count | 0 |
SMILES | CCCC/C=C\CCCCCCCC1=CC(=O)C2=CC=CC=C2N1C |
InChi Key | HWFYWIVOYBPLQU-SREVYHEPSA-N |
InChi Code | InChI=1S/C23H33NO/c1-3-4-5-6-7-8-9-10-11-12-13-16-20-19-23(25)21-17-14-15-18-22(21)24(20)2/h6-7,14-15,17-19H,3-5,8-13,16H2,1-2H3/b7-6- |
Chemical Name | 1-methyl-2-[(Z)-tridec-8-enyl]quinolin-4-one |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
ln Vitro | Evocarpine (1-100 μM) applied cumulatively suppresses the sustained induced contraction by 60 mM K+ in a concentration-dependent manner [1]. In promyelocytic leukemia HL-60 cells, evocarpine has been shown to cause apoptotic cell death in time- and dose-dependent ways[3]. |
References |
[1]. The vasorelaxant effect of evocarpine in isolated aortic strips: mode of action. Eur J Pharmacol. 1988 Oct 11;155(1-2):139-43. [2]. Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine. J Appl Microbiol. 2015 Apr;118(4):864-72. [3]. Cyclic adenosine monophosphate inhibits quinolone alkaloid evocarpine-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells. Pharmacol Toxicol. 2000 Jul;87(1):1-5. |
Additional Infomation |
Evocarpine is a member of quinolines. Evocarpine has been reported in Tetradium ruticarpum with data available. |
Solubility Data
Solubility (In Vitro) | DMSO : 100 mg/mL (294.54 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.36 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 2.5 mg/mL (7.36 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (7.36 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.9454 mL | 14.7271 mL | 29.4542 mL | |
5 mM | 0.5891 mL | 2.9454 mL | 5.8908 mL | |
10 mM | 0.2945 mL | 1.4727 mL | 2.9454 mL |